Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Protagen Protein Services Merges with GeneWerk to Integrate Leading Protein and Gene Therapy Analytic Platforms
Protagen Protein Services (PPS) today announced that it will merge with GeneWerk, an Ampersand portfolio […]
Clinical Research Practitioners (CRPs) Sign Up to New Accredited Register
The National Institute for Health Research (NIHR) has announced the launch of a new professional […]
Oncodesign, Covalab, CheMatech and ABX-CRO Launch DRIVE™-MRT, a Premium Complete, Integrated Service Offer for Radiopharmaceuticals Drug Discovery and Generation
ONCODESIGN (ALONC -FR0011766229), a French biopharmaceutical company dedicated to precision medicine, Covalab (Bron, France), a biotechnology company specializing […]
Doctrin Raises €13 Million to Accelerate International Expansion
Swedish health tech company Doctrin raises €13 million to fuel further expansion. The round is led by […]
SHINE Medical Technologies Closes $150-million Series C-5 Financing to Advance Nuclear Fusion-Based Technologies
SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. […]
Ixaka and SomaLogic Enter Research Collaboration to Develop Bispecific Agents for Oncology
Ixaka Ltd and SomaLogic today announce a research collaboration to support the development of aptamer-based […]
Presidio Medical Announces Appointment of New Chief Executive Officer
Presidio Medical, Inc., a clinical-stage medical device company developing a transformational neuromodulation platform, today announced […]
CMR Surgical Raises $600 Million in Series D Financing
CMR Surgical (CMR or “the Company”), a global surgical robotics business, today announces that it […]
Healthcare Sector Remains Top Target for Cybercrime, as NCSC Defends the UK Health Industry From Over 700 Cyber-attacks During Pandemic
Cyber-security experts at Infuse Technology, an IT Managed Service Provider, have warned of the dangers […]
Amphista Therapeutics Expands Research Team by Appointing Martin O'Rourke as Head of Drug Discovery and James Osborne as Director of Chemistry
Amphista Therapeutics, a Targeted Protein Degradation (TPD) biopharmaceutical company creating first-in-class cancer therapeutics that harness […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more